Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2019-07-04 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the presentation of "additional interim results of the PIVOTAL study" at a conference (ASAIO). It details clinical findings (autoregulation success, number of transplants, duration of support) and includes commentary from the CEO. This format—a brief announcement highlighting key periodic operational/clinical updates rather than a comprehensive financial statement (like 10-K or IR)—is characteristic of an Earnings Release (ER). Although the content is clinical/operational, the structure and timing (July 4, 2019) suggest it is an unscheduled update or a release tied to a specific event, fitting the ER category better than a general Regulatory Filing (RNS) or a specific Management Discussion (MDA), as it focuses on immediate results presentation.
2019-07-04 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and provides a "Bilan semestriel du contrat de liquidité" (Semi-annual balance sheet of the liquidity contract) as of June 28, 2019, detailing share and cash balances, and transaction volumes for the first half of 2019. This is a routine disclosure related to market making/liquidity provision, which is a specific type of corporate action disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or an Interim Report (IR). It is a specific announcement regarding financing/market activity, but it is not a general capital change (CAP) or share repurchase (POS). Since it is a specific, periodic announcement concerning market operations and not a primary financial statement or a general regulatory filing, it fits best under the general category for regulatory announcements that don't fit elsewhere, or potentially a specific financing/capital update. Given the options, this is a specific regulatory disclosure about market operations. It is not a standard financial report. It is most closely related to market activity disclosures. Since there isn't a specific code for 'Liquidity Contract Update', and it is a formal press release detailing financial/market data, it falls under the general Regulatory Filings (RNS) category as a miscellaneous regulatory announcement, or potentially CAP if viewed as part of ongoing financing structure maintenance. However, RNS is the designated fallback for specific announcements that don't fit the primary categories. Given the nature of the disclosure (liquidity contract balance), it is a specific corporate action announcement. I will classify it as RNS as it is a formal, periodic regulatory communication that doesn't match the other specific financial report types.
2019-07-01 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is a formal declaration dated May 22, 2019, issued by a French company (Société anonyme) and explicitly references compliance with Article 223-16 of the General Regulation of the Autorité des marchés financiers (AMF). It details the total number of shares and voting rights (BRUT and NET) as of April 30, 2019. This structure—a formal notification about the composition of the share capital and voting rights—is characteristic of regulatory filings concerning share structure changes or periodic updates required by market authorities. Since there is no specific category for 'Share Capital/Voting Rights Notification' other than the general 'Regulatory Filings' (RNS) or potentially 'Share Issue/Capital Change' (SHA), and given the explicit reference to AMF regulation regarding voting rights disclosure, it fits best as a specific regulatory disclosure. However, looking at the provided definitions, the content most closely aligns with a mandatory regulatory disclosure regarding capital structure, which is often captured under general regulatory announcements or specific capital change notices. Since it is a formal declaration of voting rights count, it is a specific regulatory filing. Given the options, 'RNS' (Regulatory Filings) is the most appropriate general category for mandatory, non-financial periodic disclosures that don't fit elsewhere, although it is highly specific content. If 'SHA' (Share Issue/Capital Change) were interpreted broadly to include capital structure reporting, it might fit, but the focus here is on voting rights disclosure. I will classify it as RNS as it is a mandatory regulatory disclosure to the AMF.
2019-05-22 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a specific operational update: 'CARMAT announces the resumption of production of prostheses for the PIVOTAL study.' This is a timely, non-periodic announcement regarding clinical trial progress and manufacturing changes, rather than a comprehensive financial report (like 10-K or IR), a formal voting result (DVA), or a management change (MANG). It is a general corporate update. Since it is a press release detailing operational and clinical progress, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard announcements that aren't covered by the more specific codes like ER, CAP, or LTR. It is not a Report Publication Announcement (RPA) because it is the primary content, not just an announcement that a report is available.
2019-05-21 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational update: the resumption of prosthesis production for the PIVOT study. It details procedural changes, timelines for patient implantation (end of Q3 2019), and future regulatory steps (submitting the dossier for CE marking in 2020). This content aligns best with an Earnings Release (ER) which covers key operational and financial highlights for a period, or potentially a Regulatory Filing (RNS) if it were a mandatory disclosure. However, since it is a formal announcement of a significant operational milestone and progress update, it functions as an Earnings Release or a general operational update. Given the options, 'ER' (Earnings Release) is the closest fit for a formal, scheduled announcement of operational progress, even if it's not strictly quarterly results. It is not a full report (10-K, IR), a transcript (CT), or a management discussion (MDA). It is a direct announcement of company news, making ER the most appropriate classification among the specific choices, although RNS is a possibility if ER is reserved strictly for financial figures. Since it contains forward-looking statements and operational progress, ER is chosen over the generic RNS.
2019-05-21 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration dated April 23, 2019, providing an update on the total number of voting rights and shares composing the capital, specifically referencing Article 223-16 of the General Regulation of the Autorité des marchés financiers (AMF). This type of filing, which reports changes in the total number of shares and voting rights, is typically classified as a notification related to capital structure or significant shareholding changes. Given the options, it most closely aligns with a notification regarding capital structure changes or a general regulatory filing. Since it explicitly details the number of shares and voting rights, it is a specific regulatory disclosure. It is not an Earnings Release (ER), Annual Report (10-K), or Interim Report (IR). It is a declaration of the total number of shares and voting rights, which is a specific type of regulatory disclosure. While it relates to capital, it is not a financing activity announcement (CAP) or a major shareholding notification (MRQ) which usually concerns specific investors crossing thresholds. It is a mandatory disclosure of the total capital structure. Given the options, this specific type of mandatory capital structure disclosure fits best under the general regulatory filing category (RNS) or potentially a specific capital/financing update (CAP) if the context implies a recent change impacting capital. However, since it is a routine, periodic disclosure of the total capital base as required by the AMF, and doesn't announce a specific transaction or fundraising event, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-standard regulatory disclosure not covered by other codes. Upon re-evaluation, this document reports the total number of shares and voting rights, which is a fundamental component of capital structure reporting. It is not a general announcement of a report (RPA). It is a specific regulatory filing. Since there isn't a dedicated 'Total Voting Rights Disclosure' code, RNS is the best fit as a general regulatory filing.
2019-04-23 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.